Literature DB >> 16598747

Existence of autocrine loop between interleukin-6 and transforming growth factor-beta1 in activated rat pancreatic stellate cells.

Hiroyoshi Aoki1, Hirohide Ohnishi, Kouji Hama, Satoshi Shinozaki, Hiroto Kita, Hironori Yamamoto, Hiroyuki Osawa, Kiichi Sato, Kiichi Tamada, Kentaro Sugano.   

Abstract

Interleukin (IL)-6 is a proinflammatory cytokine assumed to participate in pancreatic fibrosis by activating pancreatic stellate cells (PSCs). Autocrine TGF-beta1 is to central in PSC functional regulation. In this study, we examined IL-6 secretion from culture-activated rat PSCs and its regulatory mechanism. Activated PSCs express and secrete IL-6. When anti-TGF-beta1 neutralizing antibody was added in the culture medium, IL-6 secretion from activated PSCs was inhibited, whereas exogenous TGF-beta1 added in the culture medium enhanced IL-6 expression and secretion by PSCs in a dose dependent manner. Infection of PSCs with an adenovirus expressing dominant-negative Smad2/3 attenuated basal and TGF-beta1-stimulated IL-6 expression and secretion of PSCs. We also demonstrated the reciprocal effect of PSCs-secreted IL-6 on autocrine TGF-beta1. Anti-IL-6 neutralizing antibody inhibited TGF-beta1 secretion from PSCs. Preincubation of cells with 10 nM PD98059, an extracellular signal-regulated kinase (ERK)-dependent pathway inhibitor, attenuated IL-6-enhanced TGF-beta1 expression and secretion of PSCs. In addition, IL-6 activated ERK in PSCs. These data indicate the existence of autocrine loop between IL-6 and TGF-beta1 through ERK- and Smad2/3-dependent pathways in activated PSCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598747     DOI: 10.1002/jcb.20906

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  29 in total

1.  Apigenin Decreases Acinar Cell Damage in Pancreatitis.

Authors:  Amy A Mrazek; Vandanajay Bhatia; Miriam Falzon; Heidi Spratt; Celia Chao; Mark R Hellmich
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

2.  Mathematical model of chronic pancreatitis.

Authors:  Wenrui Hao; Hannah M Komar; Phil A Hart; Darwin L Conwell; Gregory B Lesinski; Avner Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

3.  Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein.

Authors:  Steven O'Reilly; Marzena Ciechomska; Rachel Cant; Jacob M van Laar
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

Review 4.  Signal transduction in pancreatic stellate cells.

Authors:  Atsushi Masamune; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

Review 5.  Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancer.

Authors:  Juan L Iovanna; David L Marks; Martin E Fernandez-Zapico; Raul Urrutia
Journal:  Am J Pathol       Date:  2013-01-31       Impact factor: 4.307

Review 6.  Cancer associated fibroblasts in cancer pathogenesis.

Authors:  Omar E Franco; Aubie K Shaw; Douglas W Strand; Simon W Hayward
Journal:  Semin Cell Dev Biol       Date:  2009-11-05       Impact factor: 7.727

Review 7.  Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer.

Authors:  Annarosa Arcangeli; Olivia Crociani; Lapo Bencini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

8.  Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts.

Authors:  L Gallelli; D Falcone; G Pelaia; T Renda; R Terracciano; N Malara; A Vatrella; A Sanduzzi; B D'Agostino; F Rossi; C Vancheri; R Maselli; S A Marsico; R Savino
Journal:  Cell Prolif       Date:  2008-04-24       Impact factor: 6.831

9.  Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice.

Authors:  L R Luckett-Chastain; R M Gallucci
Journal:  Br J Dermatol       Date:  2009-04-29       Impact factor: 9.302

Review 10.  Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis.

Authors:  Kyoko Shimizu
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.